ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 350895 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 350895; 2) Community: the network communities that were significantly associated with the response to NSC 350895; 3) Molecule: the relationships between components within communities and NSC 350895; 4) MDR: the compounds that were significantly associated with the NSC 350895.

NSC Compound Enrichment Correlation
NSC 684459 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 4-(4-bromo- phenyl)-5,6-dihydro-2-phenyl- 0.0115521552688258 0.19638904
NSC 711104 Null 0.0115521552688258 0.19806981
NSC 719177 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, 1-adamantaneethyl ester 0.0115521552688258 -0.14714997
NSC 720248 Null 0.0115521552688258 -0.19799177
NSC 740602 Null 0.0115521552688258 -0.06934775
NSC 111533 Methoxycamptothecin 0.0123744972338278 0.4868418
NSC 245398 Null 0.0123744972338278 -0.17939897
NSC 31709 Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride 0.0123744972338278 -0.21901456
NSC 46401 .alpha.-Sarcin 0.0123744972338279 0.50280869
NSC 606498 Camptothecin Derivative 0.0123744972338279 0.3944842
Total:63  Current:18    [First] [Prev] [Next] [Last]